Thursday, November 27, 2025 | 09:50 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

MSD launches gender-neutral HPV vaccine in India, licences Covid jab

HPV infections are one of the leading causes of cervical cancer in women

pharmacy, drugs, medicine, pharma companies, pharmaceuticals, vaccine, coronavirus, covid, testing
premium

Sohini Das Mumbai
MSD Pharmaceuticals, a wholly-owned subsidiary of Merck Sharp & Dohme, launched India’s first gender neutral HPV vaccine Gardasil 9. This nine-valent Human Papillomavirus vaccine would work against nine variants of HPV and is for use in girls (9- to 26-year-old) and boys (9-15-year-old).

HPV is responsible for causing cervical cancer, which can be detected through a simple screening procedure called the pap smear test. Boys also need to be vaccinated as they are often carriers of HPV.

Rehan A Khan, Managing Director, MSD-India Region said that the vaccine will be imported into the country. “There is a large cohort of